Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01760694 · ClinicalTrials.gov registry record · NA
Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer
A NA study, sponsored by Southwestern Regional Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01760694: Clinical Trial NA study, sponsored by Southwestern Regional Medical Center.
NCT01760694 is a NA study that was terminated before completion, run by Southwestern Regional Medical Center. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01760694, a NA study, was terminated before completion, sponsored by Southwestern Regional Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
To assess the ability of a combination of updated and approved modalities in the treatment of first line pancreatic cancer patients to increase the time to Progression Free Survival
Primary Outcome
Interim analysis at specific time points. Measure disease response by CT scans per standard of care or when clinically indicated.
Interventions
- OTHER Multi-Modality; IORT, Surgery, Radiation, Chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-07 |
| Phase | NA |
Why NCT01760694 stopped before completion
NCT01760694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Multi-Modality; IORT, Surgery, Radiation, Chemotherapy is the first listed.
NCT01760694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01760694 about?
NCT01760694 is a clinical study titled "Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer". To assess the ability of a combination of updated and approved modalities in the treatment of first line pancreatic cancer patients to increase the time to Progression Free Survival
What is the current status of trial NCT01760694?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2013-01. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01760694?
The interventions under investigation include: Multi-Modality; IORT, Surgery, Radiation, Chemotherapy (OTHER).
Who is sponsoring clinical trial NCT01760694?
This trial is sponsored by Southwestern Regional Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01760694's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia